Sector 10 (OTCMKTS:SECI) vs. Zynex (NASDAQ:ZYXI) Head to Head Comparison

Sector 10 (OTCMKTS:SECI – Get Free Report) and Zynex (NASDAQ:ZYXI – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation.

Profitability

This table compares Sector 10 and Zynex’s net margins, return on equity and return on assets.

Institutional and Insider Ownership

29.7% of Zynex shares are owned by institutional investors. 9.2% of Sector 10 shares are owned by company insiders. Comparatively, 49.3% of Zynex shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and target prices for Sector 10 and Zynex, as reported by MarketBeat.

Given Sector 10’s higher probable upside, analysts plainly believe Sector 10 is more favorable than Zynex.

Earnings and Valuation

This table compares Sector 10 and Zynex”s revenue, earnings per share and valuation.

Zynex has higher revenue and earnings than Sector 10. Zynex is trading at a lower price-to-earnings ratio than Sector 10, indicating that it is currently the more affordable of the two stocks.

About Sector 10

(Get Free Report)

Sector 10, Inc., a development stage company, markets MRU SRU product lines and various solutions related to mobile assets. Sector 10, Inc. was incorporated in 1992 and is based in Bellevue, Washington.

About Zynex

(Get Free Report)

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.